Osteoarthritis, Osteophytes, and Enthesophytes Affect Biomechanical Function in Adults With X-linked Hypophosphatemia

被引:36
|
作者
Steele, Amy [1 ]
Gonzalez, Ramon [2 ]
Garbalosa, Juan C. [3 ]
Steigbigel, Keith [3 ]
Grgurich, Tania [2 ]
Parisi, Erika J. [5 ]
Feinn, Richard S. [1 ]
Tommasini, Steven M. [4 ]
Macica, Carolyn M. [1 ]
机构
[1] Quinnipiac Univ, Frank H Netter MD Sch Med, Dept Med Sci, North Haven, CT 06518 USA
[2] Quinnipiac Univ, Sch Hlth Sci, Dept Diagnost Imaging, North Haven, CT 06518 USA
[3] Quinnipiac Univ, Sch Hlth Sci, Dept Phys Therapy, North Haven, CT 06518 USA
[4] Quinnipiac Univ, Sch Med, Yale Univ, Dept Orthopaed, New Haven, CT 06510 USA
[5] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA
关键词
X-linked hypophosphatemia; range of motion; gait analysis; enthesopathy; degenerative arthritis; osteophyte; PEX GENE; PHOSPHATE; THERAPY; RICKETS; PREVALENCE; MOTION; RELIABILITY; KINEMATICS; RANGE; TRUNK;
D O I
10.1210/clinem/dgaa064
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: X-Linked hypophosphatemia (XLH) is a lifelong metabolic disease with musculoskeletal comorbidities that dominate the adult clinical presentation. Objective: The adult XLH disorder has yet to be quantified on the basis of the physical and functional limitations that can affect activities of daily living. Our goal was to report the impact of the musculoskeletal manifestations on physical function. Design and setting: Musculoskeletal function was evaluated by validated questionnaires and in an interdisciplinary clinical space where participants underwent full-body radiologic imaging, goniometric range of motion (ROM) measurements, general performance tests, and kinematic gait analysis. Patients: Nine adults younger than 60 years with a diagnosis of XLH and self-reported musculoskeletal disability, but able to independently ambulate, were selected to participate. Passive ROM and gait analysis were also performed on age-approximated controls to account for differences between individual laboratory instrumentation. Results: Enthesophytes, degenerative arthritis, and osteophytes were found to be consistently bilateral and diffusely present at the spine and synovial joints across participants, with predominance at weight-bearing joints. Passive ROM in adults with XLH was decreased at the cervical spine, hip, knee, and ankle compared to controls. Gait analysis relative to controls revealed increased step width, markedly increased lateral trunk sway, and physical restriction at the hip, knees, and ankle joints that translated into limitations through the gait cycle. Conclusions: The functional impact of XLH musculoskeletal comorbidities supports the necessity for creating an interprofessional health-care team with the goal of establishing a longitudinal plan of care that considers the manifestations of XLH across the lifespan.
引用
收藏
页码:E1798 / E1814
页数:17
相关论文
共 50 条
  • [21] Consensus Recommendations for the Diagnosis and Management of X-Linked Hypophosphatemia in Belgium
    Laurent, Michael R.
    Schepper, Jean De
    Trouet, Dominique
    Godefroid, Nathalie
    Boros, Emese
    Heinrichs, Claudine
    Bravenboer, Bert
    Velkeniers, Brigitte
    Lammens, Johan
    Harvengt, Pol
    Cavalier, Etienne
    Kaux, Jean-Francois
    Lombet, Jacques
    Waele, Kathleen De
    Verroken, Charlotte
    van Hoeck, Koenraad
    Mortier, Geert R.
    Levtchenko, Elena
    Walle, Johan Vande
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [22] Lower Limb Deformity and Gait Deviations Among Adolescents and Adults With X-Linked Hypophosphatemia
    Mindler, Gabriel T.
    Kranzl, Andreas
    Stauffer, Alexandra
    Kocijan, Roland
    Ganger, Rudolf
    Radler, Christof
    Haeusler, Gabriele
    Raimann, Adalbert
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [23] Long-term Burosumab Administration Is Safe and Effective in Adults With X-linked Hypophosphatemia
    Weber, Thomas J.
    Imel, Erik A.
    Carpenter, Thomas O.
    Peacock, Munro
    Portale, Anthony A.
    Hetzer, Joel
    Merritt, J. Lawrence, II
    Insogna, Karl
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, : 155 - 165
  • [24] Burosumab for Pediatric X-Linked Hypophosphatemia
    Imel, Erik A.
    CURRENT OSTEOPOROSIS REPORTS, 2021, 19 (03) : 271 - 277
  • [25] Burosumab for Pediatric X-Linked Hypophosphatemia
    Erik A. Imel
    Current Osteoporosis Reports, 2021, 19 : 271 - 277
  • [26] Hyperparathyroidism in Patients With X-Linked Hypophosphatemia
    Lecoq, Anne-Lise
    Chaumet-Riffaud, Philippe
    Blanchard, Anne
    Dupeux, Margot
    Rothenbuhler, Anya
    Lambert, Benoit
    Durand, Emmanuel
    Boros, Erika
    Briot, Karine
    Silve, Caroline
    Francou, Bruno
    Piketty, Marie
    Chanson, Philippe
    Brailly-Tabard, Sylvie
    Linglart, Agnes
    Kamenicky, Peter
    JOURNAL OF BONE AND MINERAL RESEARCH, 2020, 35 (07) : 1263 - 1273
  • [27] Joint replacement in X-linked hypophosphatemia
    Mills, Emily S.
    Iorio, Louis
    Feinn, Richard S.
    Duignan, Kevin M.
    Macica, Carolyn M.
    JOURNAL OF ORTHOPAEDICS, 2019, 16 (01) : 55 - 60
  • [28] Clinical and Genetic Characteristics of 153 Chinese Patients With X-Linked Hypophosphatemia
    Lin, Xiaoyun
    Li, Shanshan
    Zhang, Zhenlin
    Yue, Hua
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [29] Prevalence and clinical characteristics of X-linked hypophosphatemia in Parana, southern Brazil
    Moreira, Carolina Aguiar
    Lemos Costa, Tatiana M. R.
    Oberger Marques, Julia Vieira
    Sylvestre, Lucimary
    Almeida, Ana Cristina R.
    Maluf, Eliane M. C. P.
    Borba, Victoria Z. C.
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2020, 64 (06): : 796 - 802
  • [30] Impaired mineral quality in dentin in X-linked hypophosphatemia
    Coyac, Benjamin R.
    Falgayrac, Guillaume
    Penel, Guillaume
    Schmitt, Alain
    Schinke, Thorsten
    Linglart, Agnes
    McKee, Marc D.
    Chaussain, Catherine
    Bardet, Claire
    CONNECTIVE TISSUE RESEARCH, 2018, 59 : 91 - 96